Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


PCORI Grant Process Begins, But Challenge Of Involving Nontraditional Researchers Remains

Executive Summary

The Patient-Centered Outcomes Research Institute approved its priorities and research agenda May 21, and revealed funding amounts for clinical comparative research the following day. But, as the board of governors’ discussion showed, one of PCORI’s biggest challenges remains how to bring in nontraditional researchers to help give its research a uniquely patient-centered focus.

You may also be interested in...

PCORI To Solicit More Head-To-Head Comparative Studies

The Patient-Centered Outcomes Research Institute announces plans to encourage the submission of more proposals for head-to-head clinical comparative effectiveness studies. Among the research topics the institute will encourage are the Institute of Medicine’s top 100 priorities and recommendations from America’s Health Insurance Plans.

Antibiotics Go Head-To-Head In PCORI-Funded Observational Study

Patient-Centered Outcomes Research Institute selected five drug-related research topics for funding, including a look at narrow- versus broad-spectrum antibiotics for acute respiratory tract infections in children, though all studies are observational. PCORI approved 52 CER projects in this third funding round, including many declined in the first round.

PCORI Research Applications: Fewer Than Expected, Geographically Limited

The Patient-Centered Outcomes Research Institute will look for more ways to engage the research community, particularly in Midwestern states, as the number of applications for research grants has fallen short of expectations.

Related Content





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts